Earnings Per Share (Tables)

3 Months Ended

Sep. 30, 2022

The following table reflects the calculation of basic and diluted earnings per share (in thousands, except per share amounts):


	Quarter Ended
	September 30,
	2022		2021
Earnings per share – basic:
Net earnings, including noncontrolling interest	$	89,734	$	68,981
Less net earnings (loss) attributable to noncontrolling interest		179		(634)
Net earnings attributable to Bio-Techne	$	89,555	$	69,615
Income allocated to participating securities		(26)		(36)
Income available to common shareholders	$	89,529	$	69,579
Weighted-average shares outstanding – basic		39,232		39,094
Earnings per share – basic	$	2.28	$	1.78

Earnings per share – diluted:
Net earnings, including noncontrolling interest	$	89,734	$	68,981
Less net earnings (loss) attributable to noncontrolling interest		179		(634)
Net earnings attributable to Bio-Techne	$	89,555	$	69,615
Income allocated to participating securities		(26)		(36)
Income available to common shareholders	$	89,529	$	69,579
Weighted-average shares outstanding – basic		39,232		39,094
Dilutive effect of stock options and restricted stock units		1,311		2,064
Weighted-average common shares outstanding – diluted		40,543		41,158
Earnings per share – diluted	$	2.21	$	1.69